Most Common Cancers in Women, Ranked by New Cases

Breast cancer ranks first among cancers in women worldwide by a wide margin, accounting for roughly one in four new female cancer diagnoses each year. After breast cancer, the most frequently diagnosed cancers in women are lung, colorectal, cervical, and endometrial (uterine body), with thyroid cancer also ranking high in many countries. The global picture from the latest GLOBOCAN estimates puts female breast cancer at about 2.3 million new cases annually, making it second only to lung cancer when both sexes are counted together.¹ But the ranking alone misses the more revealing story: which of these cancers are climbing, which are preventable, and why the same cancer can be a manageable diagnosis in one country and a death sentence in another.

Breast Cancer Dominates the List

Breast cancer’s position at the top of the ranking is not new, but the gap between it and every other cancer in women has been widening. Every year, more than two million women globally receive a breast cancer diagnosis, and the number continues to grow as populations age and as screening detects tumors that previously went unnoticed until they caused symptoms.² Among younger women under 40, breast cancer remains the leading malignancy, with the heaviest burden of both new cases and deaths falling on this diagnosis compared with cervical, ovarian, or uterine cancers.³

The risk factors driving breast cancer incidence are a mix of things you can change and things you cannot. Family history, genetic predisposition, breast density, and prior breast cancer history are beyond anyone’s control.⁴ On the modifiable side, reproductive patterns matter in ways that surprise many people. Each birth lowers the long-term risk by about 7%, and every 12 months of breastfeeding adds another 4% reduction on top of that.⁵ But timing complicates the picture. A recent pregnancy temporarily raises breast cancer risk in the short term, particularly for estrogen-receptor-negative subtypes, before conferring long-term protection decades later.⁶ Women in high-income countries tend to have fewer children and have them later, which partly explains why breast cancer incidence is highest in wealthier nations.

Screening mammography, for all the debate it generates, does reduce deaths. A study following over half a million women found that those who participated in screening had a 41% lower risk of dying from breast cancer within ten years and a 25% lower rate of advanced-stage disease compared with non-participants.⁷ The trade-off is overdiagnosis, where screening finds slow-growing tumors that would never have caused harm. But the mortality benefit remains clear in the data, and it is the main reason breast cancer survival rates are high in countries where screening programs are well-established.

Lung Cancer in Women

Lung cancer is the leading cause of cancer death in both sexes and the most commonly diagnosed cancer worldwide when men and women are counted together.¹ Among women alone, it typically ranks second after breast cancer in terms of new diagnoses, and its deadliness gives it outsized importance in the overall burden of cancer on women’s lives.

One persistent misconception is that lung cancer is almost exclusively a smoker’s disease. Smoking is the dominant risk factor, no question. But lung cancer in people who have never smoked is a recognized and growing concern, particularly among women. A large study of married couples where neither partner smoked found that the risk of lung cancer was higher in the female partners than in the male partners, with adenocarcinoma, a subtype not as tightly linked to smoking, accounting for the vast majority of cases.⁸ The reasons are still being investigated, but hormonal factors, differences in carcinogen metabolism, and household exposures like cooking fumes and radon have all been proposed. This is one area where the “just don’t smoke” advice, while valuable, is incomplete.

Colorectal Cancer and the Shift Toward Younger Adults

Colorectal cancer ranks third among cancers in women globally. In older adults, rates have been declining for decades, thanks largely to colonoscopy screening catching and removing precancerous polyps. But a troubling counter-trend has emerged: the incidence has nearly doubled in adults under 50 since the early 1990s. Roughly one in ten colorectal cancer diagnoses now occurs in someone 50 or younger, and three-quarters of those younger patients have no family history of the disease.⁹

The rise isn’t uniform across sexes or geography. In some countries the increase has been steeper in young men, while in others, including England, Norway, and Australia, the rise has been faster among young women.¹⁰ The leading suspects are generational changes in diet, sedentary behavior, obesity, and possibly shifts in the gut microbiome. Diet is a major determinant of gut microbial composition, and researchers have been examining how Western dietary patterns, high in processed meat and low in fiber, may alter the microbial environment in ways that promote colorectal tumor development.¹¹ The practical takeaway is that young women experiencing persistent changes in bowel habits, unexplained bleeding, or abdominal pain should not assume they are too young for colorectal cancer. Many screening guidelines now recommend starting at age 45 rather than 50.

Cervical Cancer Is the Most Preventable Cancer on the List

Cervical cancer sits around fourth or fifth place globally in women’s cancer incidence, but its significance goes far beyond the raw numbers. Nearly all cervical cancer cases, about 99.7%, are caused by persistent infection with high-risk strains of human papillomavirus (HPV).¹² Each high-grade precancerous lesion is typically driven by a single HPV type, meaning that vaccination targeting the most dangerous strains can prevent the overwhelming majority of cases.¹³

The real-world data on HPV vaccination is striking. A population-level study in England found reductions consistent with an 80% decrease in cervical precancerous lesions and cancers in cohorts offered routine vaccination as adolescents.¹⁴ Girls vaccinated at age 16 or younger showed the strongest protection, with roughly an 86% lower rate of cervical cancer compared with unvaccinated women.¹⁵ This makes cervical cancer something of a paradox in global health: we possess the tools to virtually eliminate it, yet it remains one of the leading cancer killers of women in low-income countries where vaccination and screening coverage are low.

Among younger women in low-HDI countries, cervical cancer has the highest ratio of deaths to new diagnoses of any female-specific cancer, meaning that once diagnosed, survival is disproportionately poor.³ That gap has nothing to do with biology and everything to do with access to care.

Endometrial, Thyroid, and Ovarian Cancers

Endometrial cancer (cancer of the uterine lining) has been rising in many countries, closely tracking the global increase in obesity. More than half of endometrial cancers are currently attributable to excess body weight, making it the cancer most tightly linked to the obesity epidemic.¹⁶ The mechanism involves fat tissue producing estrogen, which stimulates the uterine lining. The more excess fat, the more unopposed estrogen exposure the endometrium receives. This is one of the clearest examples in oncology of a lifestyle factor directly fueling cancer growth.

Thyroid cancer is an unusual entrant on the list because its ranking has changed dramatically over the past few decades, driven largely by the widespread use of ultrasound imaging of the neck. Women are diagnosed with thyroid cancer at consistently higher rates than men across the globe.¹⁷ Part of that sex difference is biological, likely related to hormonal and immune factors, but a substantial portion is detection-driven: women undergo more neck imaging during pregnancy evaluations, fertility workups, and carotid artery screenings, leading to incidental discovery of small thyroid nodules that might never have caused harm. This has fueled an ongoing debate about overdiagnosis, where an increase in detected cases has not been matched by a corresponding rise in deaths.

Ovarian cancer ranks lower in incidence than the cancers above but carries disproportionate lethality because it tends to be caught late. There is no effective population-level screening test for ovarian cancer, and symptoms like bloating and pelvic discomfort are easily mistaken for less serious conditions. Global models project that ovarian cancer cases will continue to rise through 2050.¹⁸

Alcohol, Obesity, and the Risk Factors That Cut Across Multiple Cancers

Several modifiable risk factors show up again and again across the most common cancers in women. Alcohol consumption is one of the better-established ones, though many women are unaware that it raises breast cancer risk at all. A meta-analysis found that women who consume alcohol have roughly three and a half times the risk of breast cancer compared with non-drinkers.¹⁹ The risk climbs further when alcohol is combined with excess body fat. A large UK study of nearly 400,000 adults found that the combination of above-guideline drinking and high body-fat percentage produced the highest cancer incidence, with the joint effect looking worse than either factor alone.²⁰

Obesity itself raises risk for at least a dozen cancer types, but its effect on endometrial cancer is the most dramatic, as noted earlier. For colorectal cancer, the role of diet extends beyond weight. What you eat shapes the gut microbiome, and a fiber-poor, red-meat-heavy diet alters microbial metabolites in ways researchers believe promote tumor formation in the colon.¹¹ The practical thread connecting all of this is that maintaining a healthy weight, limiting alcohol, and eating a diet rich in fiber and low in processed meat would reduce the incidence of several of the cancers on this list simultaneously.

Why the Same Cancer Kills More Women in Poorer Countries

One of the most uncomfortable realities in women’s cancer is the disparity between where cancers are diagnosed and where women die from them. High-income and upper-middle-income countries account for about three-quarters of all breast cancer cases but a lower share of deaths, while women in the poorest countries bear a disproportionately high mortality burden, especially those under 50.²¹ Overall cancer death rates have been higher among women in low- and middle-income countries despite their lower overall incidence rates, largely because of inadequate access to early detection and treatment.²²

Cervical cancer illustrates this disparity most starkly. In countries with high vaccination coverage and organized screening, cervical cancer is becoming rare. In sub-Saharan Africa and parts of South Asia, it remains one of the top killers of women of reproductive age. The tools exist to prevent virtually every case. The bottleneck is delivery infrastructure, cold chains for vaccines, trained clinicians, and accessible treatment centers.

For breast cancer, some very-high-HDI countries have achieved mortality declines of 2.5% or more per year, meeting the targets set by the WHO’s Global Breast Cancer Initiative.²³ Meanwhile, projections suggest that by 2050, new cases and deaths from breast cancer will have increased by 38% and 68% respectively, with the growth concentrated in low-HDI countries that lack the screening and treatment infrastructure to catch up.

Life After Treatment

Because survival rates for many of the most common women’s cancers have improved dramatically, especially breast cancer, there is a growing population of women living with the long-term aftereffects of treatment. Chemotherapy in particular leaves a lasting footprint. In a study of women with early-stage breast cancer who had completed chemotherapy, about a third reported worsening fatigue, roughly a third reported a decline in physical well-being, and close to a third experienced deterioration in social well-being.²⁴ Emotional well-being fared somewhat better, with about 8% reporting worsening in that domain, but the physical toll was substantial and persistent.

These findings have pushed researchers toward “prehabilitation,” the idea that interventions before treatment, including exercise programs, nutritional support, and psychological preparation, could blunt the severity of long-term side effects. The concept is still maturing, but it reflects a broader shift in oncology from focusing solely on survival to paying attention to what quality of life looks like after the tumor is gone. For women facing treatment for any of the cancers on this list, asking about prehabilitation options before starting chemotherapy or surgery is a reasonable step.

Occupational and Environmental Exposures

Headlines about chemicals causing cancer generate anxiety, but the epidemiological evidence for most occupational and environmental exposures is thinner than people expect. A study in Singapore examined whether long-term occupational exposure to endocrine-disrupting chemicals raised breast cancer risk and found no association.²⁵ That doesn’t close the book on environmental chemicals and cancer, but it does illustrate why researchers describe the evidence as “equivocal” for breast cancer specifically.

Colorectal cancer may be a different story. A Canadian cohort study found that occupational exposure to certain anti-estrogenic endocrine disruptors was associated with about a 31% higher colorectal cancer risk. Exposure to arsenic and polychlorinated biphenyls (PCBs) carried even higher risks in the same analysis.²⁶ These are occupational-level exposures, not the trace amounts found in household products. But for women working in industries with heavy chemical exposure, including manufacturing, agriculture, and waste management, the colorectal cancer signal is worth paying attention to and discussing with occupational health providers.

Autoimmune Conditions and Cancer Risk in Women

Women are far more likely than men to develop autoimmune diseases, from rheumatoid arthritis to lupus to psoriasis. Because chronic inflammation is a known contributor to cancer, you might expect autoimmune conditions to raise cancer risk across the board. The reality is more nuanced. A systematic review and meta-analysis examining the relationship between autoimmune diseases and female-specific cancers found that for some cancer sites, autoimmune conditions were actually associated with a decreased risk. The researchers noted that estrogen, which plays both anti-inflammatory and pro-inflammatory roles in the immune system, may partly explain this unexpected finding. Conditions like rheumatoid arthritis, psoriasis, and ankylosing spondylitis have been linked to lower estrogen levels, which could reduce the hormone-driven cancer risk in organs like the breast and uterus while raising other risks.²⁷ Much remains unclear here, but the simplistic “inflammation equals cancer” equation does not hold neatly when hormones are part of the picture.

Where the Numbers Are Heading

Projections to 2050 paint a mixed picture. Breast cancer and ovarian cancer cases are expected to increase globally, driven by aging populations and the adoption of Western dietary and reproductive patterns in countries that previously had lower incidence.¹⁸ Cervical cancer and uterine cancer, by contrast, are expected to decline, largely thanks to HPV vaccination programs and improved screening. The breast cancer projections are sobering: a 38% increase in new cases and a 68% increase in deaths by 2050, with the burden falling hardest on countries least equipped to handle it.²³ The colorectal cancer trend in younger adults adds another layer of concern, since no current projection model fully accounts for whatever is driving that generational shift. The cancers most common in women today will still be the most common in 2050, but the geography of who suffers and dies from them is likely to change considerably.

1
PubMed Central. Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries
2
PubMed Central. The global burden of women’s cancers: a grand challenge in global health
3
PubMed Central. Female cancers in adolescent and young adult women: global inequities and 2050 burden estimates from GLOBOCAN 2022
4
PubMed Central. Modifiable and Nonmodifiable Risk Factors for Breast Cancer: A Comprehensive Scoping Review
5
PubMed Central. Breastfeeding reduces the risk of breast cancer: A call for action in high-income countries with low rates of breastfeeding
6
JAMA Network Open. Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial Risk
7
PubMed Central. Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women
8
Lung Cancer. Higher lung cancer risk among female never-smokers than males in a large married couple study
9
PubMed Central. Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults
10
The Lancet. Global patterns and trends in colorectal cancer incidence in young versus older adults from 1943 to 2017: an epidemiological study
11
PubMed Central. Diet, Gut Microbiota, and Colorectal Cancer Prevention: A Review of Potential Mechanisms and Promising Targets for Future Research
12
PubMed Central. Human papillomavirus and cervical cancer
13
PubMed. Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion?
14
PubMed Central. Association between HPV vaccination and cervical screening policy changes and cervical cancer incidence and grade-3 cervical intraepithelial neoplasia incidence in England, 2006-2020
15
PubMed Central. Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer
16
PubMed Central. Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment
17
PubMed Central. Examining Why Thyroid Cancer Incidence Is High in Women
18
PubMed Central. Global, regional, and national burden of breast, cervical, uterine, and ovarian cancer and their risk factors among women from 1990 to 2021, and projections to 2050
19
Journal of Epidemiology and Public Health. Meta-Analysis: Obesity, Smoking, and Alcohol Consumption as risk Factors of Breast Cancer
20
PubMed Central. Joint association of alcohol consumption and adiposity with alcohol- and obesity-related cancer in a population sample of 399,575 UK adults
21
PubMed Central. Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies?
22
Cancer Epidemiology, Biomarkers & Prevention. Global Cancer in Women: Burden and Trends
23
PubMed. Global patterns and trends in breast cancer incidence and mortality across 185 countries
24
PubMed. Identifying pre-habilitation targets for the mitigation of long-term side effects of chemotherapy in patients with early breast cancer
25
BMC Public Health. Occupational Exposure to Endocrine Disrupting Substances and the Risk of Breast Cancer: The Singapore Chinese Health Study
26
Environmental Research. Occupational exposure to endocrine-disrupting chemicals and colorectal cancer risk – An analysis of four participating cohorts of the Canadian Partnership for Tomorrow’s Health study
27
Journal of Autoimmunity. Autoimmune diseases and female-specific cancer risk: A systematic review and meta-analysis